GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avant Diagnostics Inc (GREY:AVDX) » Definitions » Market Cap

Avant Diagnostics (Avant Diagnostics) Market Cap : $7,416.48 Mil (As of Apr. 30, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Avant Diagnostics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Avant Diagnostics's share price for the quarter that ended in Dec. 2018 was $0.02. Avant Diagnostics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2018 was 336.96 Mil. Therefore, Avant Diagnostics's market cap for the quarter that ended in Dec. 2018 was $6.74 Mil.

Avant Diagnostics's quarterly market cap stayed the same from Jun. 2018 ($10.11 Mil) to Sep. 2018 ($10.11 Mil) but then declined from Sep. 2018 ($10.11 Mil) to Dec. 2018 ($6.74 Mil).

Avant Diagnostics's annual market cap declined from Sep. 2016 ($54.81 Mil) to Sep. 2017 ($6.08 Mil) but then increased from Sep. 2017 ($6.08 Mil) to Sep. 2018 ($10.11 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Avant Diagnostics's Enterprise Value for Today is $7,416.48 Mil.


Avant Diagnostics Market Cap Historical Data

The historical data trend for Avant Diagnostics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avant Diagnostics Market Cap Chart

Avant Diagnostics Annual Data
Trend Oct09 Oct10 Oct11 Oct12 Oct13 Sep14 Sep15 Sep16 Sep17 Sep18
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.22 28.78 54.81 6.08 10.11

Avant Diagnostics Quarterly Data
Jan14 Apr14 Jul14 Oct14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.14 6.74 10.11 10.11 6.74

Competitive Comparison of Avant Diagnostics's Market Cap

For the Diagnostics & Research subindustry, Avant Diagnostics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avant Diagnostics's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avant Diagnostics's Market Cap distribution charts can be found below:

* The bar in red indicates where Avant Diagnostics's Market Cap falls into.



Avant Diagnostics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Avant Diagnostics's Market Cap for the fiscal year that ended in Sep. 2018 is calculated as

Market Cap (A: Sep. 2018 )=Share Price (A: Sep. 2018 )*Shares Outstanding (EOP) (A: Sep. 2018 )
=$0.03*336.958
=$10.11

Avant Diagnostics's Market Cap for the quarter that ended in Dec. 2018 is calculated as

Market Cap (Q: Dec. 2018 )=Share Price (Q: Dec. 2018 )*Shares Outstanding (EOP) (Q: Dec. 2018 )
=$0.02*336.958
=$6.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avant Diagnostics  (GREY:AVDX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Avant Diagnostics Market Cap Related Terms

Thank you for viewing the detailed overview of Avant Diagnostics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Avant Diagnostics (Avant Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
1050 30th Street NW, Suite 107, Washington, DC, USA, 20007
Avant Diagnostics Inc is a medical diagnostic technology company. Business activity of the group is functioned through United States. It focuses on the commercialization of a series of proprietary microarray-based diagnostic tests that provide early detection of cancers, neurodegenerative diseases, and other chronic and severe disease states. The company's premier product is OvaDx, a non-invasive proteomics diagnostic screening test for the early detection of ovarian cancer.